QANDLI DIABET KASALLIGIDA GAZLI GANGRENA QO’ZG’ATUVCHISINING AHAMIYATI
Keywords:
Qandli diabet, gazli gangrena, Clostridium perfringens, alfa toksin, anaerob infeksiya, gipoksiya, diabetik tovon sindromi.Abstract
Maqolada qandli diabet fonida gazli gangrena qo‘zg‘atuvchisi bo‘lmish Clostridium perfringens ning mikrobiologik ahamiyati adabiyotlar tahlili asosida ko‘rib chiqilgan. Asosiy e’tibor giperglikemiya va to‘qima gipoksiyasining klostridiyalar ko‘payishi hamda alfa-toksin ishlab chiqarishini jadallashtirishiga qaratilgan. Tahlillar shuni ko‘rsatadiki, qandli diabet asoratlari bakteriyalar uchun boy ozuqa muhiti va qulay anaerob sharoit yaratib, kasallikning o‘ta og‘ir kechishiga sabab bo‘ladi. Maqolada erta mikrobiologik tashxis va kompleks davolash strategiyalarining samaradorligi asoslab berilgan.
References
Armstrong D.G., et al., 2023. Diabetic Foot Ulcers and Their Infection Complications. New England Journal of Medicine, 376(24): p. 2367-2375.
Bakker D.J., et al., 2023. Hyperbaric oxygen therapy in the treatment of gas gangrene in diabetic patients. Undersea & Hyperbaric Medicine, p. 89-94.
Boulton A.J., et al., 2024. The Diabetic Foot: Epidemiology and Microbiology of Anaerobic Infections. Diabetes Care Journal, p. 112-118.
Bryant A.E., et al., 2020. Clostridial myonecrosis: new insights into pathogenesis and treatment. Current Opinion in Infectious Diseases, p. 167-173.
Centers for Disease Control and Prevention, 2025. Clostridium perfringens: Clinical Features and Laboratory Diagnosis. CDC, Atlanta, p. 10-12.
Finegold S.M., 2012. Anaerobic Bacteria in Human Disease. Academic Press, London, p. 310-325.
Hatheway C.L., 2010. Toxigenic Clostridia and their role in soft tissue infections. Clinical Microbiology Reviews, p. 15-28.
International Diabetes Federation, 2024. IDF Diabetes Atlas, 11th edition. Brussels, Belgium, p. 12-24.
Ismoilov M.I., 2024. Diabetik tovon sindromida klostridial infeksiyalarning o'rni. Pediatriya jurnali (Toshkent), 2-son.
Kuznetsov N.A., et al., 2022. Analiz letal'nosti pri gazoobrazuyushchey infektsii u bol'nykh s sakharnym diabetom (Qandli diabeti bor bemorlarda gaz hosil qiluvchi infeksiyada o'lim ko'rsatkichlari tahlili). Khirurgicheskaya praktika, 14(2): p. 30-37.
Lipsky B.A., et al., 2025. Infectious Diseases Society of America (IDSA) Guidelines on Diabetic Foot Infections. Clinical Infectious Diseases, p. 1-25.
Merck Manuals, 2025. Gas Gangrene (Clostridial Myonecrosis) and Diabetes Mellitus. Professional Edition, p. 5-9.
Privolnev V.V., 2023. Anaerobnaya infektsiya v khirurgii (Xirurgiyada anaerob infeksiya). Klinicheskaya mikrobiologiya i antimikrobnaya khimioterapiya, 25(1): p. 5-18.
Sodiqov A.S., 2023. Qandli diabet asoratlarida anaerob mikrobiota tahlili. O'zbekiston tibbiyot jurnali, 3-son, 45-50-betlar.
Spilsbury K., et al., 2024. Impact of glycemic control on the progression of soft tissue infections. Journal of Diabetes and Its Complications, p. 77-84.
Stevens D.L., Bryant A.E., 2022. Necrotizing Soft Tissue Infections: Gas Gangrene and Beyond. The Journal of Infectious Diseases, PubMed ID: 28407133, p. 47-50.
Svetlukhin A.M., et al., 2021. Gnilostnaya infektsiya myagkikh tkaney u bol'nykh sakharnym diabetom (Qandli diabeti bor bemorlarda yumshoq to'qimalarning chirindi infeksiyasi). Khirurgiya. Zhurnal im. N.I. Pirogova, str. 14-22.
Titball R.W., 2023. The role of alpha-toxin in the development of gas gangrene. Vaccine, 36 Suppl 2: p. A15- A22.
World Health Organization (WHO), 2025. Global report on the burden of surgical site infections and anaerobic complications. WHO Press, Geneva, p. 45-48.
Zubair M., et al., 2024. Microbiology of Diabetic Foot Infections: A 10-year retrospective analysis. PubMed Central (PMC), ID: PMC8845120, p. 158-162.





